Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Acadia Pharmaceuticals buy Bank of America Co.

Acadia Pharmaceuticals
Start price
€22.15
30.06.26 / 50%
Target price
€26.32
30.06.27
Performance (%)
13.09%
Price
€25.05
17.08.26
Summary
This prediction is currently active. The BUY prediction by Bank_of_America_Co_ currently has a performance of 13.09%. This prediction currently runs until 30.06.27. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Acadia Pharmaceuticals -1.649% -1.649%
iShares Core DAX® -0.046% 5.960%
iShares Nasdaq 100 0.922% 3.693%
iShares Nikkei 225® 3.014% 6.638%
iShares S&P 500 -0.359% 2.747%

Comments by Bank_of_America_Co_ for this prediction

In the thread Acadia Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 13.09%
Target price 26.319
Change
Ends at 30.06.27

ACADIA Pharmaceuticals (ACAD) had its price target raised by Bank of America Corporation from $29.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat

Bank of America Co. 
0
Report Share
30.06.26

Stopped prediction by Bank_of_America_Co_ for Acadia Pharmaceuticals

buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€19.04
25.03.26
€24.99
25.03.27
31.57%
17.08.26

Bank of America Co. 
25.03.26 50%